Financial Data : CAPEX, Depreciation/Amortization and R&D
The Company has adopted International Financial Reporting Standards(IFRS) from the fiscal year ended December 31, 2020.
CAPEX & Depreciation/Amortization
R&D Expenses
| (bil.yen) | Japanese GAAP | IFRS | |||
|---|---|---|---|---|---|
| 2016 | 2017 | 2018 | 2019 | 2020 | |
| Capital Expenditure | 194.1 | 234.8 | 268.4 | 328.2 | 271.9 |
| Depreciation and amortization | 188.0 | 200.3 | 200.4 | 269.7 | 267.5 |
| % to Revenue | 5.6 | 5.5 | 5.5 | 7.7 | 8.9 |
| R&D Expenses | 95.4 | 99.7 | 103.5 | 106.2 | 95.2 |
| % to Revenue | 2.9 | 2.7 | 2.8 | 3.0 | 3.2 |
